Measures · D08 in 2018 · Part D · DD3 Member Experience with the Drug Plan
Rating of Drug Plan
Drug PlanMember ExperienceSource: CAHPS
- What it measures
- Percent of the best possible score the plan earned from members who rated the prescription drug plan.
- How it's calculated
- This case-mix adjusted measure is used to assess members' overall view of their prescription drug plan. The Consumer Assessment of Healthcare Providers and Systems (CAHPS) score uses the mean of the distribution of responses converted to a scale from 0 to 100. The score shown is the percentage of the best possible score each contract earned.
- Data source
- CAHPS CAHPS Survey Questions (question numbers vary depending on survey type): • Using any number from 0 to 10, where 0 is the worst prescription drug plan possible and 10 is the best prescription drug plan possible, what number would you use to rate your prescription drug plan?
- Measurement period
- 03/2017 – 06/2017
- Better when
- Higher
- Weight
- 1.5 (Patients’ Experience and Complaints Measure)
- Star assignment
- Relative Distribution and Significance Testing
- Case-mix adjusted
- —
- In improvement measure
- Yes
- Used in CAI
- No
- Notes
- CAHPS Survey results were sent to each contract's Medicare Compliance Officer in August 2017. These reports provide further explanation of the CAHPS scoring methodology and provide detailed information on why a specific rating was assigned.
From the 2018 Star Ratings Technical Notes (CMS).
Cut points over time
Score needed to earn each star level. Part D thresholds differ for MA-PD and standalone PDP contracts. Dotted lines and open dots: where the cut points may move for 2028.
How the 2028 cut points are projected
Each boundary moves by its median year-on-year change since 2019. It's the same projection the Star outlook uses for every contract. CMS sets real cut points from all contracts' scores each year, so treat these as a direction, not a forecast of the exact number.
| Stars | Org type | 2027 | Projected 2028 | Move |
|---|---|---|---|---|
| 2★ | MA-PD | 84 | 85 | +1 |
| 3★ | MA-PD | 86 | 86 | 0 |
| 4★ | MA-PD | 87 | 87 | 0 |
| 5★ | MA-PD | 89 | 89 | 0 |
| 2★ | PDP | 82 | 82 | 0 |
| 3★ | PDP | 83 | 83 | 0 |
| 4★ | PDP | 86 | 86 | 0 |
| 5★ | PDP | 88 | 88 | 0 |
2018 star distribution
Not rated: Plan too small to be measured (103); Plan too new to be measured (83); Plan not required to report measure (15); Not enough data available (1)
Cut point bands
| Star year | Org type | 1★ | 2★ | 3★ | 4★ | 5★ |
|---|---|---|---|---|---|---|
| 2027 | MA-PD | < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 to < 89 | >= 89 |
| 2027 | PDP | < 82 | >= 82 to < 83 | >= 83 to < 86 | >= 86 to < 88 | >= 88 |
| 2026 | MA-PD | < 85 | >= 85 to < 86 | >= 86 to < 88 | >= 88 to < 89 | >= 89 |
| 2026 | PDP | < 82 | >= 82 to < 83 | >= 83 to < 86 | >= 86 to < 88 | >= 88 |
| 2025 | MA-PD | < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 to < 89 | >= 89 |
| 2025 | PDP | < 79 | >= 79 to < 82 | >= 82 to < 85 | >= 85 to < 87 | >= 87 |
| 2024 | MA-PD | < 84 | >= 84 to < 85 | >= 85 to < 87 | >= 87 to < 89 | >= 89 |
| 2024 | PDP | < 80 | >= 80 to < 81 | >= 81 to < 83 | >= 83 to < 87 | >= 87 |
| 2023 | MA-PD | < 83 | >= 83 to < 85 | >= 85 to < 87 | >= 87 to < 88 | >= 88 |
| 2023 | PDP | < 79 | >= 79 to < 80 | >= 80 to < 83 | >= 83 to < 87 | >= 87 |
| 2022 | MA-PD | < 84 | >= 84 to < 85 | >= 85 to < 87 | >= 87 to < 88 | >= 88 |
| 2022 | PDP | < 80 | >= 80 to < 82 | >= 82 to < 84 | >= 84 to < 87 | >= 87 |
| 2021 | MA-PD | < 83 | >= 83 to < 84 | >= 84 to < 86 | >= 86 to < 87 | >= 87 |
| 2021 | PDP | < 80 | >= 80 to < 81 | >= 81 to < 83 | >= 83 to < 87 | >= 87 |
| 2020 | MA-PD | < 83 | ? 83 to < 84 | ? 84 to < 86 | ? 86 to < 87 | ? 87 |
| 2020 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 83 | ? 83 to < 87 | ? 87 |
| 2019 | MA-PD | < 82 | ? 82 to < 83 | ? 83 to < 85 | ? 85 to < 87 | ? 87 |
| 2019 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 84 | ? 84 to < 86 | ? 86 |
| 2018 | MA-PD | < 81 | ? 81 to < 83 | ? 83 to < 85 | ? 85 to < 86 | ? 86 |
| 2018 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 83 | ? 83 to < 87 | ? 87 |
| 2017 | MA-PD | < 80 | ? 80 to < 82 | ? 82 to < 84 | ? 84 to < 86 | ? 86 |
| 2017 | PDP | < 79 | ? 79 to < 80 | ? 80 to < 83 | ? 83 to < 86 | ? 86 |
| 2016 | MA-PD | < 80 | ? 80 to < 82 | ? 82 to < 84 | ? 84 to < 86 | ? 86 |
| 2016 | PDP | < 80 | ? 80 to < 81 | ? 81 to < 82 | ? 82 to < 86 | ? 86 |
| 2015 | MA-PD | < 82% | ? 82% to < 83% | ? 83% to < 84% | ? 84% to < 87% | ? 87% |
| 2015 | PDP | < 80% | ? 80% to < 81% | * | ? 81% to < 86% | ? 86% |
Lowest-scoring contracts, 2018
| Contract | Parent | Members | Score | Stars | Δ | Shortfall to 4★ | Pctile |
|---|---|---|---|---|---|---|---|
| R3332 Florida Blue | Guidewell Mutual Holding Corporation | — | 75 | 1 | 0 | 10 | 0% |
| S5904 Florida Blue | Guidewell Mutual Holding Corporation | 46,802 | 77 | 1 | 0 | 6 | 0% |
| S5921 UnitedHealthcare | UnitedHealth Group, Inc. | 2,326,418 | 77 | 1 | 0 | 6 | 0% |
| S6506 Blue Cross Blue Shield of Arizona (AZ Blue) | Blue Cross Blue Shield of Arizona | — | 77 | 1 | 0 | 6 | 0% |
| H4922 AgeWell New York | ParkerCare New York, LLC | — | 76 | 1 | — | 9 | 0% |
| H3152 Aetna Medicare | CVS Health Corporation | 30,674 | 77 | 1 | 0 | 8 | 1% |
| H8649 Aetna Medicare | CVS Health Corporation | 1,503 | 77 | 1 | 0 | 8 | 1% |
| H3206 Presbyterian Insurance Company, Inc. | Presbyterian Healthcare Services | — | 78 | 1 | −3 | 7 | 1% |
| H4213 Arkansas Blue Medicare | USAble Mutual Insurance Company | 2,258 | 78 | 1 | −1 | 7 | 1% |
| H7245 Premera Blue Cross Medicare Advantage | Premera | — | 78 | 1 | 0 | 7 | 1% |
| H3154 Horizon Blue Cross Blue Shield of New Jersey | Horizon Healthcare Services, Inc. | — | 78 | 1 | −1 | 7 | 1% |
| H1659 UnitedHealthcare | UnitedHealth Group, Inc. | 2,487 | 79 | 1 | −1 | 6 | 2% |
| H8854 CareFirst BlueCross BlueShield Advantage DualPrime | CareFirst, Inc. | 8,599 | 79 | 1 | — | 6 | 2% |
| H2450 Medica | Medica Holding Company | 117,203 | 79 | 1 | −1 | 6 | 2% |
| H3312 Aetna Medicare | CVS Health Corporation | 105,069 | 79 | 1 | 0 | 6 | 2% |
| H3931 Aetna Medicare | CVS Health Corporation | 70,785 | 79 | 1 | −1 | 6 | 2% |
| R6694 Aetna Medicare | CVS Health Corporation | 899 | 79 | 1 | — | 6 | 2% |
| H9915 Medstar Family Choice, Inc. | Medstar Health, Inc. | — | 79 | 1 | −1 | 6 | 2% |
| H1666 Blue Cross and Blue Shield of NM, TX | Health Care Service Corporation | 15,741 | 79 | 1 | −1 | 6 | 2% |
| H3597 Aetna Medicare | CVS Health Corporation | 22,853 | 79 | 1 | −1 | 6 | 2% |
| H3404 Blue Cross and Blue Shield of North Carolina | CuraCor Solutions Corp. | 36,785 | 80 | 1 | −1 | 5 | 4% |
| H1304 Regence BlueShield of Idaho | Cambia Health Solutions, Inc. | 902 | 80 | 1 | −1 | 5 | 4% |
| H2241 Golden State | MacArthur Court Acquisition Corp | — | 80 | 1 | −2 | 5 | 4% |
| H3379 UnitedHealthcare | UnitedHealth Group, Inc. | 102,401 | 80 | 1 | −1 | 5 | 4% |
| R5342 UnitedHealthcare | UnitedHealth Group, Inc. | 0 | 80 | 1 | −1 | 5 | 4% |
History
| Star year | Code | Name | Measured | Weight | Source |
|---|---|---|---|---|---|
| 2027 | D05 | Rating of Drug Plan | 03/2026 – 06/2026 | 2 | CAHPS |
| 2026 | D05 | Rating of Drug Plan | 03/2025 – 05/2025 | 2 | CAHPS |
| 2025 | D05 | Rating of Drug Plan | 03/2024 – 06/2024 | 4 | CAHPS |
| 2024 | D05 | Rating of Drug Plan | 03/2023 – 06/2023 | 4 | CAHPS |
| 2023 | D05 | Rating of Drug Plan | 03/2022 – 06/2022 | 4 | CAHPS |
| 2022 | D05 | Rating of Drug Plan | 03/2021 – 05/2021 | 2 | CAHPS |
| 2021 | D07 | Rating of Drug Plan | 03/2019 – 05/2019 | 2 | CAHPS |
| 2020 | D07 | Rating of Drug Plan | 03/2019 – 05/2019 | 1.5 | CAHPS |
| 2019 | D07 | Rating of Drug Plan | 03/2018 – 06/2018 | 1.5 | CAHPS |
| 2018 | D08 | Rating of Drug Plan | 03/2017 – 06/2017 | 1.5 | CAHPS |
| 2017 | D08 | Rating of Drug Plan | 02/2016 – 08/2016 | 1.5 | CAHPS |
| 2016 | D08 | Rating of Drug Plan | 02/15/2015 - 05/31/2015 | 1.5 | CAHPS |
| 2015 | D06 | Rating of Drug Plan | 02/15/2014 - 05/31/2014 | 1.5 | CAHPS |